1. Billionaire Tim Draper – $250k Bitcoin, 2022 year end
    Stock-to-flow model by Plan B – $288k Bitcoin, 2021 year end
    Citibank – $318k Bitcoin, 2021 year end
    Scott from Guggenheim – $400k Bitcoin
    JP Morgan – $600k Bitcoin.

  2. SIGL is gone explode,check this out Moe,massive oportunity. This stock is gone be huuge,buy the dip now and you gone have good return on this beast🚀🚀🚀🍾🍾

  3. 👉🏻 ATNF (180 Life Sciences) Under the radar gem is an understatement. Potentially and very likely will trade 30X or more current stock price in due time. Co-Founded by Prof. Raphael Mechoulam "THE GODFATHER Of Cannabis Research" Discovered the Endocannabinoid system and isolating the two primary compounds, CBD and THC. ATNF has about a Tiny 1 million share true float with an addressable $150 Billion worldwide pipelines to address unmet needs of the number #1 cause of all autoimmune diseases in the world (Inflammation) and Chronic Pain Therapies with the Best Minds in the world. Dream Team All Star Management created drugs and companies that sold for well over $100 Billion developing some of the most widely used therapies in the world. They are in Phase 3 the last phase of a potential $7.5 Billion (UK and US) and probably $20+ Billion worldwide therapy for Early Dupuytren’s Disease which there is NO other treatment available (NO competition). Phase 2 exceeded all primary endpoints. They are fully funded with grants (only the best of the best 1% ers receives grants) and cash on hand as per CEO in their latest presentation on January 11th 2021. Market cap is tiny around $80 million. The patent portfolio covers 16 patent families with 42 patents issues and 32 pending in several important jurisdictions including the US, Canada, Europe, Australia, Japan and China. The 74 Incredible Patent portfolio alone is worth 8X the current stock price with more patents to be added as they are processed. Management owns 50% of the outstanding shares and 72% of outstanding shares cannot be sold for 12 Months.

    *Vanguard took a 13%stake in the company in a 13G filings On February 10th 2021 buying a total of 2,250,000 shares for 2 separate Vanguard Funds. In March 1st Vanguard index funds bought 101,639 shares probably a starter position. Total shares bought 2,356,000

    👉🏻PT: $115,00 – $150.00 if gets FDA approval for Early Dupuytren’s therapy. Results of phase 3 coming in few months
    👉🏻Add $100.00 on to Dupuytren’s therapy PT for any subsequent FDA
    👉🏻PT: $600.00++ If successful on the CBD pipeline therapies to disrupt and replace the addictive and deadly opioid market.

Leave a Reply

Your email address will not be published.